Partnership enhances patient enrollment efficiency and expands site network capabilities using LLMs

ClinTrial Research , a leading site management organization, announced a strategic partnership with Trially, the latest breakthrough in HIPAA-compliant AI matching technology. After six months of collaboration, the partnership has shown significant improvements in patient identification, enrollment speed, and operational efficiency.

“Trially’s proprietary AI has improved our ability to pre-screen candidates, reducing the time and resources typically spent on manual EHR chart reviews while improving the diversity and quality of our patient pools.”

Health Technology Insights: Fujifilm Expands Partnership with NRHA to Enhance Medical Imaging Access in Rural Areas

How Native AI Technology is Advancing Site Operations

By implementing Trially’s AI EMR matching technology, CTR has experienced notable improvements in its clinical trial operations:

  • Increased monthly patient enrollment rates
  • Significant reduction in screen failures
  • Less time spent on manual EHR chart reviews
  • Increased site revenue due to higher study KPIs
  • Enhanced diversity through real-time protocol population analytics
  • Instant API integrations with multiple EHR systems including IMS, TriMed, Athena, RelyMed, and others
  • Expanded site network capabilities, with successful implementations across multiple therapy areas including Behavioral Health and CNS, Respiratory, Internal Medicine Gastrointestinal, Nephrology and Ophthalmology

“Our mission at CTR is to build the premier, next-generation site management organization, setting new standards of excellence in clinical trial management,” said ClinTrial Research’s Chief Commercial Officer, Sam Searcy. “Our partnership with Trially aligns perfectly with our commitment to using AI-driven data analytics and high-precision patient identification to accelerate clinical trial timelines. Trially’s proprietary AI has improved our ability to pre-screen candidates, reducing the time and resources typically spent on manual EHR chart reviews while improving the diversity and quality of our patient pools.”

Health Technology Insights: ElevateBio Appoints Ger Brophy, Ph.D., as Interim Chief Executive Officer

Setting New Standards for AI Clinical Trial Enrollment

The partnership demonstrates CTR’s commitment to setting new standards of excellence in clinical trial management and represents a significant step forward in Trially’s mission to get life-saving therapies to patients faster. Both organizations share a vision of accelerating the development of new treatments through more efficient, transparent, and inclusive clinical trials.

“We built Trially to solve the root causes of clinical trial delays,” said Trially CEO Kyle McAllister. “The team at CTR has done an amazing job integrating our technology into their workflow. Their network of clinical partners really knows how to put our platform to work, making it their top source for finding qualified patients. What impresses me most is how CTR balances technological efficiency with their unwavering commitment to patient care and data security. It’s been rewarding to see how they’ve adapted our solution across different systems to accelerate their enrollment timelines.”

Health Technology Insights: Moleculin Gets EMA Approval to Expand Phase 3 MIRACLE Trial

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – businesswire